Page last updated: 2024-08-23

cromolyn sodium and Pancreatic Neoplasms

cromolyn sodium has been researched along with Pancreatic Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, CE; Kim, JS; Lim, SK1
Arumugam, T; Bornmann, WG; Logsdon, CD; Maxwell, DS; Pal, A; Peng, Z; Ramachandran, V; Sun, D1
Arumugam, T; Logsdon, CD; Ramachandran, V1
Theoharides, TC1

Other Studies

4 other study(ies) available for cromolyn sodium and Pancreatic Neoplasms

ArticleYear
In vivo antitumor effect of cromolyn in PEGylated liposomes for pancreatic cancer.
    Journal of controlled release : official journal of the Controlled Release Society, 2012, Jan-30, Volume: 157, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cromolyn Sodium; Female; Humans; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Phosphatidylcholines; Polyethylene Glycols; Tumor Burden; Xenograft Model Antitumor Assays

2012
Designing and developing S100P inhibitor 5-methyl cromolyn for pancreatic cancer therapy.
    Molecular cancer therapeutics, 2013, Volume: 12, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Calcium-Binding Proteins; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Cromolyn Sodium; Drug Design; Drug Evaluation, Preclinical; Humans; Male; Mice; Mice, Nude; Neoplasm Proteins; NF-kappa B; Pancreatic Neoplasms; Protein Binding; Receptor for Advanced Glycation End Products; Tumor Burden; Xenograft Model Antitumor Assays

2013
Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models.
    Journal of the National Cancer Institute, 2006, Dec-20, Volume: 98, Issue:24

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Chromatography, Affinity; Cromolyn Sodium; Deoxycytidine; Drug Synergism; Flow Cytometry; Gemcitabine; Gene Expression Regulation, Neoplastic; Genes, Reporter; Immunoprecipitation; Luciferases; Mice; Neoplasm Invasiveness; NF-kappa B; Pancreatic Neoplasms; Receptor for Advanced Glycation End Products; Receptors, Immunologic; S100 Proteins

2006
Mast cells and pancreatic cancer.
    The New England journal of medicine, 2008, Apr-24, Volume: 358, Issue:17

    Topics: Animals; Cell Transformation, Neoplastic; Chemokine CCL2; Cromolyn Sodium; Mast Cells; Mice; Neovascularization, Pathologic; Pancreatic Neoplasms; Proto-Oncogene Proteins c-myc

2008